1. Home
  2. CCTG vs SABS Comparison

CCTG vs SABS Comparison

Compare CCTG & SABS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CCTG
  • SABS
  • Stock Information
  • Founded
  • CCTG 1993
  • SABS 2014
  • Country
  • CCTG Hong Kong
  • SABS United States
  • Employees
  • CCTG N/A
  • SABS N/A
  • Industry
  • CCTG
  • SABS Biotechnology: Pharmaceutical Preparations
  • Sector
  • CCTG
  • SABS Health Care
  • Exchange
  • CCTG Nasdaq
  • SABS Nasdaq
  • Market Cap
  • CCTG 18.9M
  • SABS 19.0M
  • IPO Year
  • CCTG 2024
  • SABS N/A
  • Fundamental
  • Price
  • CCTG $1.52
  • SABS $1.25
  • Analyst Decision
  • CCTG
  • SABS Strong Buy
  • Analyst Count
  • CCTG 0
  • SABS 5
  • Target Price
  • CCTG N/A
  • SABS $11.40
  • AVG Volume (30 Days)
  • CCTG 40.6K
  • SABS 38.1K
  • Earning Date
  • CCTG 12-27-2024
  • SABS 05-19-2025
  • Dividend Yield
  • CCTG N/A
  • SABS N/A
  • EPS Growth
  • CCTG N/A
  • SABS N/A
  • EPS
  • CCTG N/A
  • SABS N/A
  • Revenue
  • CCTG $16,463,490.00
  • SABS $1,322,410.00
  • Revenue This Year
  • CCTG N/A
  • SABS N/A
  • Revenue Next Year
  • CCTG N/A
  • SABS $25.00
  • P/E Ratio
  • CCTG N/A
  • SABS N/A
  • Revenue Growth
  • CCTG 3.27
  • SABS N/A
  • 52 Week Low
  • CCTG $1.20
  • SABS $1.11
  • 52 Week High
  • CCTG $3.41
  • SABS $5.01
  • Technical
  • Relative Strength Index (RSI)
  • CCTG 40.16
  • SABS 31.17
  • Support Level
  • CCTG $1.50
  • SABS $1.11
  • Resistance Level
  • CCTG $1.79
  • SABS $1.80
  • Average True Range (ATR)
  • CCTG 0.16
  • SABS 0.16
  • MACD
  • CCTG -0.01
  • SABS -0.01
  • Stochastic Oscillator
  • CCTG 4.26
  • SABS 18.42

About CCTG CCSC Technology International Holdings Limited

CCSC Technology International Holdings Ltd along with its subsidiaries is involved in the sale, design, and manufacturing of interconnect products, including connectors, cables, and wire harnesses. Its products include customized interconnect products, including connectors, cables, and harnesses that are used for a range of applications in a diversified set of industries, including industrial, automotive, robotics, medical equipment, computer, network and telecommunication, and consumer products. Geographically, the company generates maximum revenue from the sale of its products in Europe and the rest from the Americas and Asia.

About SABS SAB Biotherapeutics Inc.

SAB Biotherapeutics Inc is a clinical stage biopharmaceutical company focused on the development and commercialization of a portfolio of products from its proprietary immunotherapy platform to produce fully targeted human polyclonal antibodies, without using human plasma or serum. The company's novel DiversitAb platform enables the rapid production of large amounts of targeted human polyclonal antibodies, leveraging transchromosomic cattle (Tc Bovine) that have been genetically designed to produce human antibodies (immunoglobulin G) rather than bovine in response to an antigen. Animal antibodies have been made in rabbits, sheep and horses.

Share on Social Networks: